Powered by 
Translate
TranslateKRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company") extends its congratulations to its partner and majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp., on receiving national recognition from the Bolivian Chamber of Commerce and Industry (ICAMC) for its outstanding contributions to the pharmaceutical manufacturing sector.
The distinction was awarded as part of Bolivia's "Hecho en Bolivia" ("Made in Bolivia") campaign, which highlights companies that represent the nation through quality manufacturing, innovation, and a sustained commitment to excellence. The recognition reaffirms SIGMA’s leadership in advancing pharmaceutical production that aligns with both local public health priorities and international quality standards.
"This recognition reaffirms the decades of leadership and impact that SIGMA has delivered to the people of Bolivia," said Cesar Herrera, CEO of KRTL Holding Group Inc. "We are proud to work alongside a company that exemplifies what it means to serve both local communities and international markets."
Guided by the leadership of Patricia Wilstermann, SIGMA has consistently demonstrated excellence across five decades in Bolivia's pharmaceutical sector. The company’s facility in Cochabamba adheres to globally recognized Good Manufacturing Practices (GMP), positioning SIGMA to support both local healthcare delivery and international distribution efforts as part of its integration with KRTL Biotech, Inc.
The honor was publicly shared by ICAMC via LinkedIn and can be viewed here: https://www.linkedin.com/posts/icamcbba_hechoenbolivia-activity-7387648988000460800-3MgA
"SIGMA has always worked with integrity and purpose, and this recognition belongs to our entire team," said Patricia Wilstermann, CEO of SIGMA Corp. "We remain committed to building a pharmaceutical sector in Bolivia that delivers trust, efficacy, and innovation."
KRTL Holding views this recognition as a further validation of its strategic merger and its vision to bring South American pharmaceutical excellence into new global markets through collaborative partnerships, regulatory alignment, and investment in regional capabilities.
About KRTL Holding Group, Inc.
KRTL Holding Group, Inc. (OTC: KRTL) operates through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp. The Company leverages strategic synergies across biotech, technology, and emerging markets to drive growth and deliver shareholder value.
About KRTL Biotech, Inc.
KRTL Biotech, Inc., a 51% majority-owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), recently completed a merger with Industria Químico-Farmacéutica SIGMA Corp. S.R.L., integrating SIGMA’s decades of pharmaceutical expertise and infrastructure into KRTL’s international life sciences platform. This merger combines KRTL’s research, compliance, and global market access with SIGMA’s advanced Bolivian manufacturing capabilities, aligning both companies to deliver world-class pharmaceutical and nutraceutical solutions.
About Industria Químico Farmacéutica SIGMA Corp SRL
SIGMA is a Bolivian pharmaceutical manufacturer with more than five decades of experience in formulation, quality manufacturing, and commercialization of essential and complementary health products, including pharmaceuticals and nutraceuticals.
For more information:
www.krtlholding.com | www.krtl-icc.com | www.krtlbiotech.com | www.sigmacorp.com.bo/en/about
Forward-Looking Statements
This press release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking statements” within the meaning of applicable securities legislation. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as “anticipates,” “will,” “believes,” “plans,” “expects,” “intends,” “projects,” “estimates,” “future,” and “opportunity” and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments and acquisitions; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law.
